National Institute on Minority Health and Health Disparities; Notice of Meeting, 50428-50429 [2013-20051]
Download as PDF
<![CDATA[
50428
Federal Register / Vol. 78, No. 160 / Monday, August 19, 2013 / Notices
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Advisory Council
Date: September 11, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Stephen C. Mockrin, Ph.D.
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, (301) 435–0260, mockrins@
nhlbi.nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: August 13, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–20047 Filed 8–16–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
TKELLEY on DSK3SPTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Mar<15>2010
17:51 Aug 16, 2013
Jkt 229001
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Ancillary
R01 Studies on Liver Diseases PAR–12–265.
Date: September 23, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Diabetic
Ketoacidosis.
Date: September 24, 2013.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: D.G. Patel, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 756, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–12–265 NIDDK
Ancillary Studies to Major Ongoing Clinical
Research on Stone (R01).
Date: October 15, 2013.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call),
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 13, 2013.
Melanie Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–20053 Filed 8–16–13; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: September 10, 2013.
Closed: 8:00 a.m. to 9:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Minority Health and
Health Disparities, 6707 Democracy Blvd.,
Rm. 849, Bethesda, MD 20892.
Open: 9:30 a.m. to 5:00 p.m.
Agenda: The agenda will include opening
remarks, administrative matters, Director’s
Report, NIH Health Disparities update, and
other business of the Council.
Place: National Institutes of Health,
National Institute on Minority Health and
Health Disparities, 6707 Democracy Blvd.,
Rm. 849, Bethesda, MD 20892.
Contact Person: Donna Brooks, Executive
Officer, National Institutes of Health,
National Institute on Minority Health and
Heath Disparities, 6707 Democracy Blvd.,
Suite 800, Bethesda, MD 20892, (301) 435–
2135, brooksd@ncmhd.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
E:\FR\FM\19AUN1.SGM
19AUN1
Federal Register / Vol. 78, No. 160 / Monday, August 19, 2013 / Notices
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Dated: August 13, 2013.
Melanie Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–20051 Filed 8–16–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: September 13, 2013.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Dharmendar Rathore,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Rm 3134, Bethesda, MD 20892, 301–435–
2766, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Mar<15>2010
17:51 Aug 16, 2013
Jkt 229001
Dated: August 13, 2013.
Melanie Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–20055 Filed 8–16–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Evaluation of Programs To
Provide Services to Persons Who Are
Homeless With Mental and/or
Substance Use Disorders (Homeless
Programs)—New
SAMHSA is conducting a crossprogram evaluation of Projects for
Assistance in Transition from
Homelessness (PATH); Services in
Supportive Housing (SSH); and Grants
for the Benefit of Homeless Individuals
(GBHI), which includes grantee tracks
focused on SSH, General GBHI grantees,
and Cooperative Agreements to Benefit
Homeless Individuals (CABHI). The
SAMHSA Homeless Programs aim to
support local capacity to provide
services for homeless individuals with
substance abuse and/or mental health
problems. The Homeless Programs
national evaluation broadly aims to
address the contexts in which projects
operate; whether a project is
successfully implemented and provides
appropriate services to the intended
target population; and whether the
target population demonstrates
improved outcomes.
Data collection efforts for the
evaluation will include a Document
Review: Project Director Telephone
Follow-up, Site Visits, Evidence-Based
Practice (EBP) Self-Assessment, Parts 1
and 2 and Permanent Supportive
Housing (PSH) Self-Assessment which
collect grantee project characteristics,
process information such as client flow
and project logic models, barriers and
facilitators to implementation, and data
on the types of treatment and housing
services provided.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
50429
The Document Review: Project
Director Telephone Follow-up is a
telephone interview that covers the
following topics: Grantee Agency and
Project Characteristics, Target
Population, Stakeholders/Partners,
Services, EBPs/Best Practices, Housing,
Project Organization and
Implementation, Sustainability, Local
Evaluation, Technical Assistance and
Lessons Learned. Grantee project
directors from the GBHI 2010, CABHI
2011–2012, and SSH 2009–2010 cohorts
and PATH state contacts (n=158) will be
contacted to collect grantee project
information which will be used to better
understand how grantees develop their
grant projects.
Site Visit Guides consist of semistructured discussions with grantee
project directors, evaluators, financial
staff, clinical treatment staff, case
managers, housing supports staff, key
stakeholders and consumers/client
participants. This approach allows
information to be collected from
multiple perspectives giving a fuller
picture of the grant project. Seventy-five
site visits will be conducted during the
evaluation (25 per year for 3 years)—60
for GBHI, CABHI and SSH grantees and
15 for PATH grantees. Over the course
of multiple discussions the following
major topics will be covered: client level
process data (client experience with
project services and client flow through
the project), project components and
activities, costs, project services
alignment with client need, program
outputs and outcomes, training and
quality assurance, and relationships
with primary partners and stakeholders.
The EBP Self-Assessment will provide
data needed to assess and aggregate for
analyses the resources and processes
required for practice implementation,
whether the EBP services are being
delivered in accordance with their
evidence-based components and how
the practices are adapted for the
projects’ target populations, if relevant.
The EBP Self-Assessment includes two
parts. The first part is a general
overview of EBP implementation and
will be administered to all GBHI,
CABHI, and SSH grantees (n=127). The
second part is an in-depth assessment
for grantees who are implementing one
or more of the following EBPs: Assertive
Community Treatment (ACT), Integrated
Dual Disorders Treatment (IDDT),
Illness Management and Recovery
(IMR), Supported Employment (SE) and
Critical Time Intervention (CTI). The
estimated number of grantees who will
complete Part Two of the EBP
Assessment is 87.
The PSH Self-Assessment targets the
subset of grantees implementing PSH
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 78, Number 160 (Monday, August 19, 2013)]
[Notices]
[Pages 50428-50429]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-20051]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council on Minority Health and Health Disparities.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Minority Health
and Health Disparities.
Date: September 10, 2013.
Closed: 8:00 a.m. to 9:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Minority Health and Health Disparities, 6707 Democracy Blvd., Rm.
849, Bethesda, MD 20892.
Open: 9:30 a.m. to 5:00 p.m.
Agenda: The agenda will include opening remarks, administrative
matters, Director's Report, NIH Health Disparities update, and other
business of the Council.
Place: National Institutes of Health, National Institute on
Minority Health and Health Disparities, 6707 Democracy Blvd., Rm.
849, Bethesda, MD 20892.
Contact Person: Donna Brooks, Executive Officer, National
Institutes of Health, National Institute on Minority Health and
Heath Disparities, 6707 Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 435-2135, brooksd@ncmhd.nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the
[[Page 50429]]
organization represented, and a short description of the oral
presentation. Only one representative of an organization may be
allowed to present oral comments and if accepted by the committee,
presentations may be limited to five minutes. Both printed and
electronic copies are requested for the record. In addition, any
interested person may file written comments with the committee by
forwarding their statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation
of the interested person.
Dated: August 13, 2013.
Melanie Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-20051 Filed 8-16-13; 8:45 am]
BILLING CODE 4140-01-P
